Top News: #Biologics

Here are the top read news for #biologics:

Not All Biologics Equally Safe for Patients With Psoriasis:

A report of results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) suggests that treatment with adalimumab and infliximab are associated with a higher risk for serious infections than nonmethotrexate and nonbiologic therapies. The registry found no increased risk from treatment with ustekinumab and etanercept. Read more


8 Facts About Biologics for Crohn’s Disease:

Since biologic drugs first appeared as a treatment for Crohn’s disease and ulcerative colitis in the late ’90s, they’ve continued to improve the lives of many people with these digestive diseases. Here are eight facts you should know about biologics and Crohn’s disease. Read more


Medicare and RA: Price Tag Limits Use of Biologics:

In the first systematic national analysis of Medicare’s Part D coverage of biologic disease-modifying antirheumatic drugs (DMARDs), researchers in Hawaii and California report that while all Part D plans cover at least one biologic, patients bear a considerable cost-sharing burden. And that may act as a disincentive to prescribe these life-improving drugs. Read more